US Stock MarketDetailed Quotes

SAB Biotherapeutics (SABS)

Watchlist

3.520
-0.280-7.37%

Close Apr 24 15:59 ET

3.576
+0.056+1.60%

Post 20:01 ET

247.37MMarket Cap-4.46P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SAB Biotherapeutics (SABS) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-30.57%-44.78M

-76.00%-16.78M

-107.41%-13.05M

7.34%-7.15M

27.47%-7.8M

-36.52%-34.29M

29.11%-9.53M

-21.75%-6.29M

-57.53%-7.72M

-569.48%-10.75M

Net income from continuing operations

138.92%13.27M

-47.97%-16.86M

539.11%45.45M

-37.88%-10.11M

-3.40%-5.2M

19.17%-34.11M

50.15%-11.39M

-102.84%-10.35M

-6.61%-7.34M

31.66%-5.03M

Operating gains losses

-1,066.72%-62.83M

37.86%3.18M

-998,099.77%-61.6M

128.28%627.06K

7.91%-5.04M

-210.63%-5.39M

-51.83%2.31M

96.84%-6.17K

-720.10%-2.22M

-6,521.24%-5.47M

Depreciation and amortization

-35.70%3.08M

-2.85%763.3K

-20.83%765.47K

-26.61%774.52K

-60.79%778.3K

27.96%4.79M

-16.80%785.71K

-1.89%966.86K

18.27%1.06M

114.99%1.98M

Other non cash items

172.75%172.47K

1,259.23%224.24K

51.03%-23.68K

89.93%-8.6K

76.80%-19.49K

-106.39%-237.09K

-100.54%-19.34K

---48.36K

-270.80%-85.4K

-189.80%-83.99K

Change In working capital

-60.30%-3.69M

-288.27%-7.32M

-22.54%1.62M

258.02%942.8K

138.37%1.06M

-198.83%-2.3M

-340.88%-1.88M

240.24%2.1M

609.17%263.34K

-165.88%-2.77M

-Change in receivables

-1,522.83%-891.83K

-1,019.00%-386.83K

-537.88%-559.95K

167.48%21.39K

117.37%33.57K

-100.99%-54.96K

--42.09K

-64.65%127.88K

-107.90%-31.69K

-104.03%-193.23K

-Change in prepaid assets

-795.11%-5.29M

-612.67%-6.86M

8,348.53%2.13M

-138.11%-262.2K

-0.53%-291.08K

-12.77%-590.46K

31.79%-963.01K

-111.21%-25.84K

103.06%687.93K

-190.79%-289.54K

-Change in payables and accrued expense

887.87%2.42M

91.72%-70.33K

-97.57%48.43K

1,155.43%1.18M

194.82%1.27M

93.03%-307.71K

-165.51%-849.75K

309.99%1.99M

86.03%-111.71K

66.30%-1.34M

-Change in other current assets

----

-96.89%3.99K

-112.79%-18.06K

-108.29%-10.4K

-Change in other working capital

105.01%67.42K

----

101.65%4.65K

105.74%54.79K

-178.72%-1.35M

-267.89%-138.16K

102.25%28.46K

-533.08%-281.2K

-132.49%-954.98K

Cash from discontinued investing activities

Operating cash flow

-30.57%-44.78M

-76.00%-16.78M

-107.41%-13.05M

7.34%-7.15M

27.47%-7.8M

-36.52%-34.29M

29.11%-9.53M

-21.75%-6.29M

-57.53%-7.72M

-569.48%-10.75M

Investing cash flow

Cash flow from continuing investing activities

-917.42%-121.71M

-118.29%-1.71M

-11,167.05%-129.87M

-53.67%5.2M

114.90%4.67M

-7,733.63%-11.96M

13,849.21%9.33M

-2,721.23%-1.15M

49,556.96%11.22M

-147,126.32%-31.36M

Net PPE purchase and sale

-176.54%-932.66K

-1,585.10%-933.16K

--0

100.39%500

-120.86%-337.26K

18.40%-55.38K

-145.50%-100.3K

-131.49%-52.51K

-505.98%-129.07K

Net investment purchase and sale

-938.91%-120.77M

-108.24%-773K

-12,240.93%-129.87M

-53.88%5.2M

114.96%4.67M

---11.63M

--9.39M

---1.05M

--11.27M

---31.23M

Cash from discontinued investing activities

Investing cash flow

-917.42%-121.71M

-118.29%-1.71M

-11,167.05%-129.87M

-53.67%5.2M

114.90%4.67M

-7,733.63%-11.96M

13,849.21%9.33M

-2,721.23%-1.15M

49,556.96%11.22M

-147,126.32%-31.36M

Financing cash flow

Cash flow from continuing financing activities

14,452.36%168.3M

-119.21%-41.69K

25,123.21%168.69M

45.85%-173.84K

55.89%-173.99K

-101.76%-1.17M

-99.68%216.96K

-380.46%-674.13K

11.75%-321.04K

-9.62%-394.42K

Net issuance payments of debt

53.87%-418.41K

-115.16%-36.68K

94.46%-35.98K

31.10%-173.84K

30.52%-171.91K

-132.30%-907K

-49.37%241.9K

-354.77%-649.13K

30.64%-252.33K

31.59%-247.44K

Net common stock issuance

--168.73M

----

--0

----

Net preferred stock issuance

----

--0

----

Proceeds from stock option exercised by employees

--0

-99.97%20.41K

-100.00%-3

--0

980.00%20.41K

Net other financing activities

95.82%-11.96K

79.90%-5.01K

80.48%-4.88K

--0

98.76%-2.07K

---286.04K

---24.93K

---25K

---68.71K

---167.39K

Cash from discontinued financing activities

Financing cash flow

14,452.36%168.3M

-119.21%-41.69K

25,123.21%168.69M

45.85%-173.84K

55.89%-173.99K

-101.76%-1.17M

-99.68%216.96K

-380.46%-674.13K

11.75%-321.04K

-9.62%-394.42K

Net cash flow

Beginning cash position

-84.27%8.9M

220.84%29.42M

-78.59%3.69M

-59.81%5.64M

-84.27%8.9M

275.93%56.57M

278.12%9.17M

121.78%17.24M

7.46%14.03M

275.93%56.57M

Current changes in cash

103.83%1.82M

-119,310.81%-18.52M

417.41%25.77M

-166.90%-2.13M

92.24%-3.3M

-214.28%-47.43M

-99.97%15.54K

-51.78%-8.12M

160.16%3.18M

-2,039.29%-42.5M

Effect of exchange rate changes

11.48%-213.5K

-37.79%-397.86K

-178.96%-37.54K

534.31%179.4K

250.34%42.5K

-1,429.35%-241.2K

-1,691.42%-288.75K

--47.54K

--28.28K

---28.27K

End cash Position

18.03%10.5M

220.84%29.42M

-78.59%3.69M

-59.81%5.64M

-84.27%8.9M

278.12%9.17M

121.78%17.24M

7.46%14.03M

Free cash flow

-31.99%-45.71M

-84.71%-17.71M

-104.15%-13.05M

7.96%-7.15M

28.33%-7.8M

-36.79%-34.63M

29.06%-9.59M

-21.69%-6.39M

-57.87%-7.77M

-568.65%-10.88M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-30.57%-44.78M	-76.00%-16.78M	-107.41%-13.05M	7.34%-7.15M	27.47%-7.8M	-36.52%-34.29M	29.11%-9.53M	-21.75%-6.29M	-57.53%-7.72M	-569.48%-10.75M
Net income from continuing operations	138.92%13.27M	-47.97%-16.86M	539.11%45.45M	-37.88%-10.11M	-3.40%-5.2M	19.17%-34.11M	50.15%-11.39M	-102.84%-10.35M	-6.61%-7.34M	31.66%-5.03M
Operating gains losses	-1,066.72%-62.83M	37.86%3.18M	-998,099.77%-61.6M	128.28%627.06K	7.91%-5.04M	-210.63%-5.39M	-51.83%2.31M	96.84%-6.17K	-720.10%-2.22M	-6,521.24%-5.47M
Depreciation and amortization	-35.70%3.08M	-2.85%763.3K	-20.83%765.47K	-26.61%774.52K	-60.79%778.3K	27.96%4.79M	-16.80%785.71K	-1.89%966.86K	18.27%1.06M	114.99%1.98M
Other non cash items	172.75%172.47K	1,259.23%224.24K	51.03%-23.68K	89.93%-8.6K	76.80%-19.49K	-106.39%-237.09K	-100.54%-19.34K	---48.36K	-270.80%-85.4K	-189.80%-83.99K
Change In working capital	-60.30%-3.69M	-288.27%-7.32M	-22.54%1.62M	258.02%942.8K	138.37%1.06M	-198.83%-2.3M	-340.88%-1.88M	240.24%2.1M	609.17%263.34K	-165.88%-2.77M
-Change in receivables	-1,522.83%-891.83K	-1,019.00%-386.83K	-537.88%-559.95K	167.48%21.39K	117.37%33.57K	-100.99%-54.96K	--42.09K	-64.65%127.88K	-107.90%-31.69K	-104.03%-193.23K
-Change in prepaid assets	-795.11%-5.29M	-612.67%-6.86M	8,348.53%2.13M	-138.11%-262.2K	-0.53%-291.08K	-12.77%-590.46K	31.79%-963.01K	-111.21%-25.84K	103.06%687.93K	-190.79%-289.54K
-Change in payables and accrued expense	887.87%2.42M	91.72%-70.33K	-97.57%48.43K	1,155.43%1.18M	194.82%1.27M	93.03%-307.71K	-165.51%-849.75K	309.99%1.99M	86.03%-111.71K	66.30%-1.34M
-Change in other current assets	----	----	----	----	----	----	----	-96.89%3.99K	-112.79%-18.06K	-108.29%-10.4K
-Change in other working capital	105.01%67.42K	----	----	101.65%4.65K	105.74%54.79K	-178.72%-1.35M	-267.89%-138.16K	102.25%28.46K	-533.08%-281.2K	-132.49%-954.98K
Cash from discontinued investing activities
Operating cash flow	-30.57%-44.78M	-76.00%-16.78M	-107.41%-13.05M	7.34%-7.15M	27.47%-7.8M	-36.52%-34.29M	29.11%-9.53M	-21.75%-6.29M	-57.53%-7.72M	-569.48%-10.75M
Investing cash flow
Cash flow from continuing investing activities	-917.42%-121.71M	-118.29%-1.71M	-11,167.05%-129.87M	-53.67%5.2M	114.90%4.67M	-7,733.63%-11.96M	13,849.21%9.33M	-2,721.23%-1.15M	49,556.96%11.22M	-147,126.32%-31.36M
Net PPE purchase and sale	-176.54%-932.66K	-1,585.10%-933.16K	--0	--0	100.39%500	-120.86%-337.26K	18.40%-55.38K	-145.50%-100.3K	-131.49%-52.51K	-505.98%-129.07K
Net investment purchase and sale	-938.91%-120.77M	-108.24%-773K	-12,240.93%-129.87M	-53.88%5.2M	114.96%4.67M	---11.63M	--9.39M	---1.05M	--11.27M	---31.23M
Cash from discontinued investing activities
Investing cash flow	-917.42%-121.71M	-118.29%-1.71M	-11,167.05%-129.87M	-53.67%5.2M	114.90%4.67M	-7,733.63%-11.96M	13,849.21%9.33M	-2,721.23%-1.15M	49,556.96%11.22M	-147,126.32%-31.36M
Financing cash flow
Cash flow from continuing financing activities	14,452.36%168.3M	-119.21%-41.69K	25,123.21%168.69M	45.85%-173.84K	55.89%-173.99K	-101.76%-1.17M	-99.68%216.96K	-380.46%-674.13K	11.75%-321.04K	-9.62%-394.42K
Net issuance payments of debt	53.87%-418.41K	-115.16%-36.68K	94.46%-35.98K	31.10%-173.84K	30.52%-171.91K	-132.30%-907K	-49.37%241.9K	-354.77%-649.13K	30.64%-252.33K	31.59%-247.44K
Net common stock issuance	--168.73M	----	----	----	----	--0	----	----	----	----
Net preferred stock issuance	----	----	----	----	----	--0	--0	----	----	----
Proceeds from stock option exercised by employees	--0	--0	--0	--0	--0	-99.97%20.41K	-100.00%-3	--0	--0	980.00%20.41K
Net other financing activities	95.82%-11.96K	79.90%-5.01K	80.48%-4.88K	--0	98.76%-2.07K	---286.04K	---24.93K	---25K	---68.71K	---167.39K
Cash from discontinued financing activities
Financing cash flow	14,452.36%168.3M	-119.21%-41.69K	25,123.21%168.69M	45.85%-173.84K	55.89%-173.99K	-101.76%-1.17M	-99.68%216.96K	-380.46%-674.13K	11.75%-321.04K	-9.62%-394.42K
Net cash flow
Beginning cash position	-84.27%8.9M	220.84%29.42M	-78.59%3.69M	-59.81%5.64M	-84.27%8.9M	275.93%56.57M	278.12%9.17M	121.78%17.24M	7.46%14.03M	275.93%56.57M
Current changes in cash	103.83%1.82M	-119,310.81%-18.52M	417.41%25.77M	-166.90%-2.13M	92.24%-3.3M	-214.28%-47.43M	-99.97%15.54K	-51.78%-8.12M	160.16%3.18M	-2,039.29%-42.5M
Effect of exchange rate changes	11.48%-213.5K	-37.79%-397.86K	-178.96%-37.54K	534.31%179.4K	250.34%42.5K	-1,429.35%-241.2K	-1,691.42%-288.75K	--47.54K	--28.28K	---28.27K
End cash Position	18.03%10.5M	18.03%10.5M	220.84%29.42M	-78.59%3.69M	-59.81%5.64M	-84.27%8.9M	-84.27%8.9M	278.12%9.17M	121.78%17.24M	7.46%14.03M
Free cash flow	-31.99%-45.71M	-84.71%-17.71M	-104.15%-13.05M	7.96%-7.15M	28.33%-7.8M	-36.79%-34.63M	29.06%-9.59M	-21.69%-6.39M	-57.87%-7.77M	-568.65%-10.88M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

No. Symbol 5D % Chg

United Microelectronics

Middle East conflict spreads to the stock market! How should investors respond?

Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm